Close
Genesis Therapeutics
AI-driven drug discovery
Acq.
by
IPO
Genesis Therapeutics
AI-driven drug discovery
Acq.
by
IPO
Biotech / Biosecurity
Genesis Therapeutics
AI-driven drug discovery
Acq.
by
IPO
Active
Glyphic Biotechnologies
Next generation protein sequencing
Acq.
by
IPO
Glyphic Biotechnologies
Next generation protein sequencing
Acq.
by
IPO
Biotech / Biosecurity
Glyphic Biotechnologies
Next generation protein sequencing
Acq.
by
IPO
Active
Somite
Harnessing AI to usher in a new era of human repair
Acq.
by
IPO
Somite
Harnessing AI to usher in a new era of human repair
Acq.
by
IPO
Biotech / Biosecurity
Somite
Harnessing AI to usher in a new era of human repair
Acq.
by
IPO
Active
STEALTH CO
Specialized treatments for mold and biotoxin illness
Acq.
by
IPO
STEALTH CO
Specialized treatments for mold and biotoxin illness
Acq.
by
IPO
Biotech / Biosecurity
STEALTH CO
Specialized treatments for mold and biotoxin illness
Acq.
by
IPO
Stealth
STEALTH CO
Gene therapy and human capability advancements
Acq.
by
IPO
STEALTH CO
Gene therapy and human capability advancements
Acq.
by
IPO
Biotech / Biosecurity
STEALTH CO
Gene therapy and human capability advancements
Acq.
by
IPO
Stealth